the significant conjunction cFDR level of 0.05, and these shared SNPs had not been reported in previous studies. In addition, we used DAVID analysis to perform functional analysis of the shared SNPs' annotated genes and found their potential hidden associations with eGFRcrea and T2D. In this study, the cFDR method shows the feasibility to detect more genetic variants underlying the heritability of eGFRcrea and T2D, and the overlapping SNPs identified could be regarded as candidate loci that provide a thread of genetic mechanisms between eGFRcrea and T2D in future research.
Introduction
Failing to explain a substantial proportion of the heritability of complex phenotypes is often described as the "missing heritability" problem in traditional genome-wide association studies (GWAS) (Pei et al. 2014) . Heritable complex diseases and traits, including estimated glomerular filtration rate (eGFR) and T2D, are widely believed to have underlying missing heritability in previous respective GWASs. Estimated glomerular filtration rate by serum creatinine (eGFRcrea) has been one of the crucial clinical techniques to estimate the kidney function decline (Okada et al. 2012) . In standard GWAS analysis, the heritability ofand Ybarra 2005; Karaderi et al. 2015) . Heritability of T2D has been estimated ranging from 26 to 69%, but genes uncovered can only explain a small fraction of the heritability (Poulsen et al. 1999; Almgren et al. 2011) .
Much effort has been made to excavate the "missing heritability" mainly by expanding sample sizes. However, the approach, although straightforward, is highly expensive (Stahl et al. 2012) . Recently, cost-effective analytical methods, including summary statistics-based multivariate meta-analysis of GWAS using canonical correlation analysis (metaCCA) and Genetic analysis incorporating Pleiotropy and Annotation (GPA), have been developed to efficiently utilizing the existing datasets for improving the gene discovery (Chung et al. 2014; Cichonska et al. 2015 Cichonska et al. , 2016 ). In the current study, a recently developed pleiotropic-informed approach conditional false discovery rate (cFDR) was widely adopted to improve the gene discovery in schizophrenia and bipolar disorder (Andreassen et al. 2013c ), schizophrenia and cardiovascular-disease risk factors (Andreassen et al. 2013a) , and successfully discovered novel loci which indicated that the pleiotropic loci exist between two related traits/diseases. Recently, we implemented the cFDR analyses and successfully identified pleiotropic variants in our groups Greenbaum et al. 2017; Lv et al. 2017; Peng et al. 2017; Zhou et al. 2017) . Pleiotropy is defined as a single locus or gene affects more than one trait. It was conservatively estimated that 16.9% genes and 4.6% SNPs in the human genome have pleiotropic effects (Sivakumaran et al. 2011) . Incorporating these pleiotropic effects between related diseases or traits may effectively enhance the ever-larger sample sizes across existing GWAS datasets and thus will be helpful in adding to the novel discoveries of genetic associations underlying the missing heritability (Andreassen et al. 2013a (Andreassen et al. , c, 2014 Zeng et al. 2016; Greenbaum et al. 2017) .
T2D and eGFRcrea are widely believed to have some common underlying polygenic architecture. Epidemiological studies suggested that eGFR changes during the development of diabetes (Lorenzo et al. 2009 ), which links eGFR to insulin resistance (Chen et al. 2004; Lorenzo et al. 2009 ) and other potential abnormalities: increased renal gluconeogenesis (Eid et al. 2006 ) and activation of the renin-angiotensin system (Yamamoto et al. 2007) . Genes SLC9B2 and VEGFA have been reported as genetic risk loci for eGFRcrea (Eremina et al. 2007; Deisl et al. 2013) or T2D (Sharma et al. 2011; Deisl et al. 2013) in different studies, respectively. Given the close relationship of two traits in epidemiological studies (Chen et al. 2004; Eid et al. 2006; Yamamoto et al. 2007; Lorenzo et al. 2009 ) and given a few common genes reported in respective GWAS reflect that eGFRcrea and T2D may share some potential pleiotropic genetic determination, further exploration by cFDR is warranted as to be done here.
In this study, we performed genetic-pleiotropy-informed cFDR to capture additional polygenic effects associated with eGFRcrea and T2D. This method utilizes summary statistics from two independent large GWAS meta-analysis datasets of eGFRcrea (Pattaro et al. 2016 ) and T2D (Mahajan et al. 2014 ), which will increase the power of gene discovery and improve gene detection of these two related traits for those loci with potential pleiotropic variants by effectively increasing samples sizes (Andreassen et al. 2013a (Andreassen et al. , c, 2014 .
Materials and methods

GWAS datasets
The GWAS summary statistics including p values of SNPs were obtained from two available datasets. The dataset for eGFRcrea was taken from a GWAS meta-analysis of 133,413 European-ancestry subjects from 48 individual studies, which was performed by CKDGen consortium published in 2015 (https://fox.nhlbi.nih.gov/CKDGen/) (Pattaro et al. 2016 ). To our knowledge, it is the largest reported eGFRcrea-associated GWAS study to date. The dataset for T2D was taken from a total of 26,488 cases and 83,964 controls from the trans-ethnic T2D GWAS meta-analysis published in 2014 (http://www.diagramconsortium.org/downloads.html) (Mahajan et al. 2014) . Detailed information about the original data preparation and methods is provided in the following individual studies: the DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium5 (European ancestry; 12,171 cases and 56,862 controls) (Morris et al. 2012) , the Asian Genetic Epidemiology Network T2D (AGEN-T2D) Consortium11 (East Asian ancestry; 6952 cases and 11,865 controls) (Cho et al. 2012) , the South Asian T2D (SAT2D) Consortium13 (South Asian ancestry; 5561 cases and 14,458 controls) (Kooner et al. 2011) , and the Mexican American T2D (MAT2D) Consortium15 (Mexican and Mexican American ancestry; 1804 cases and 779 controls) (Parra et al. 2011) . After applying appropriate quality filters, about ~ 2.5 million SNPs have been imputed in each datasets. Genomic control (GC) was conducted twice, one before and the other after the meta-analysis, the first was before preparation within individual studies for the metaanalysis and the second was after the meta-analysis for further limiting the possibility of false positives due to the pooling of data from various studies for meta-analysis (Mahajan et al. 2014; Pattaro et al. 2016) . The detailed inclusion criteria and phenotype characteristics in different GWAS studies were described in the original publications (Mahajan et al. 2014; Pattaro et al. 2016) .
Data preparation
Several steps were involved in the data preparation. First, we checked the European ancestry cohorts for overlapping individuals included in the GWAS samples. An upper bound for the amount of sample overlap is obtainable from the original publications by comparing the sub-study definitions and sample sizes for eGFRcrea and T2D. The details were illustrated in Supplementary Table S1 and we assume this will not affect the detecting power of the cFDR analysis (LeBlanc et al. 2016) . Second, the SNPs were selected and clustered into independent loci through linkage disequilibrium (LD) (Andreassen et al. 2013b (Andreassen et al. , 2014 pruning based on r 2 > 0.2 within a window of 50 SNPs. For each window, LD was calculated between each pair of SNPs and the SNP with smaller MAF between pairs of variants was removed. Then, the window slid 5 SNPs forward and the above pruning process was repeated until there were no pairs of SNPs with high LD. The dataset was pruned using the HapMap 3 genotypes CEU (http://www.sanger.ac.uk/resources/downloads/human/hapmap3.html) and there were 100,952 variants left for our analysis. Since GC has been applied in both individual GWAS studies and original meta-analysis studies (Mahajan et al. 2014; Pattaro et al. 2016) , there is no need to reapply GC in our analysis.
Statistical analysis
Conditional quantile-quantile (Q-Q) and fold-enrichment plots for pleiotropic enrichment
Conditional Q-Q plots were constructed to evaluate the pleiotropic enrichment by conditioning the principal trait on the SNPs with varying strengths of association in the conditional trait (Andreassen et al. 2013c ). The Q-Q plots show the observed distribution of p values plotted against the expected distribution of p values under the null hypothesis. In this study, Q-Q plots were presented by − log 10 nominal p values plotted on the y-axis against − log 10 empirical conditional p values [empirical cumulative distribution functions (cdfs)] plots on the x-axis based on varying levels of p < 1, p < 0.1, p < 0.01, p < 0.001 and p < 0.0001. Leftward deflections of the observed distribution from the projected null line reflect increased tail probabilities in the distribution of test statistics (Z scores) and, consequently, an overabundance ("enrichment'') of low p values compared to that expected by chance. An increased deflection from the null line in the Q-Q plots indicates pleiotropic enrichment shared between the principal and conditional traits (Schork et al. 2013 ). Additionally, we conducted the fold-enrichment plots. The nominal p values [− log 10 (p)] are plotted on the x-axis, and fold enrichment in eGFRcrea as a function of T2D is plotted on the y-axis. We present fold-enrichment plots of nominal − log 10 (p) values for eGFRcrea SNPs below the standard GWAS threshold of p < 5 × 10 − 8 and for subsets of SNPs determined by the significance of their association with T2D and vice versa. As a supplement to confirm the pleiotropic enrichment effect, which can be completed by comparing the proportion of SNPs reaching each cutoff level in different significant groups with the group including all SNPs (p = 1). Pleiotropic enrichment is assessed by the degree of upward shift from the expected null line.
Conditional false discovery rate (cFDR) and conditional Manhattan plots
The cFDR method is an extension of standard FDR and was generated from the empirical Bayes method (Efron 2007) . The cFDR method combines summary statistics to obtain the probability of the association of the principal phenotype conditioned on the strength of association with conditional phenotype. cFDR was expressed as:
The cFDR p i |p j for each SNP was where eGFRcrea is the principal phenotype conditioned on the strength of association with T2D (eGFRcrea|T2D) and vice versa. Where p i represents the strength of association of a random SNP with the 'principal phenotype', p j is the strength of association of the same SNP with the 'conditional phenotype'.
represents the null hypothesis that a given SNP is not associated with the principal trait. In the present study, cFDR was computed for each SNP where eGFRcrea is the principal phenotype conditioned on the strength of association withT2D (eGFRcrea|T2D) and vice versa (T2D|eGFRcrea).
The conditional Manhattan plots were adopted to display the chromosomal locations of all the loci associated with eGFRcrea based on T2D and vice versa. A criterion of − log 10 (FDR) > 1.3 (corresponding to cFDR < 0.05) was used to select loci associated with eGFRcrea or T2D.
Conjunction cFDR and conjunction Manhattan plots
To detect pleiotropic loci shared between eGFRcrea and T2D, we computed the conjunction cFDR (ccFDR). It is defined as the probability that a given SNP has a false-positive association with both eGFRcrea and T2D. The ccFDR was computed as the maximum cFDR values of the two traits. SNPs with ccFDR < 0.05 will be considered significantly associated with both traits. Conjunction Manhattan plot was presented to illustrate the chromosomal locations of pleiotropic loci associated with both eGFRcrea and T2D. SNPs with − log 10 (cFDR) > 1.3 (ccFDR < 0.05) are significantly associated with both eGFRcrea and T2D.
Functional annotation analysis for pleiotropic loci
Functional annotation for pleiotropic loci associated with eGFRcrea and T2D was conducted by DAVID Bioinformatics Resources 6.8 database, which was downloaded from the DAVID Consortium (https://david.ncifcrf.gov/ home.jsp) (Huang et al. a, 2009b) .
DAVID covers multiple data resources based on functional annotation analysis, and we employed GO, INTERPRO, KEGG_PATHWAY, OMIM_DISEASE and UP_KEYWORDS in this study. Using the functional annotation analysis, we characterized the trait-associated loci based on their known biological processes and molecular functions to understand the potential biological mechanisms behind the large list of discovered genes. This analysis allows us to validate our findings by determining functional annotation of the gene sets that are significantly associated with both eGFR and T2D. In the current study, gene sets with ccFDR < 0.05 for both eGFRcrea and T2D were performed in DAVID.
Results
Assessment of pleiotropic enrichment
Conditional Q-Q plots were presented to assess the pleiotropic enrichment between eGFRcrea and T2D in Fig. 1 . Specifically, conditional Q-Q plots for eGFRcrea conditioned on T2D (eGFRcrea|T2D) and vice versa (T2D|eGFRcrea) are shown in Fig. 1a , b. As reflected in Fig. 1a , the leftward shift from the null line indicates association between SNPs with eGFRcrea conditioned on T2D for given p values. In Fig. 1b , (T2D|eGFRcrea), we obtained similar result. What's more, both in Fig. 1a , b, while we descended the thresholds at the level of − log 10 (p) > 0, − log 10 (p) > 1, − log 10 (p) > 2 , − log 10 (p) > 3 and − log 10 (p) > 4 (p < 1, p < 0.1, p < 0.01, p < 0.001, p < 0.0001), there would be greater amounts of separation in the curves. The leftward shifts suggested strong level of enrichment and great proportion of associations for eGFRcrea and T2D. Pleiotropic enrichment effects can also be assessed by the degree of upward shift from the expected null line (p = 1) in the fold-enrichment plots, and the more upward shift means more fold enrichment. Based on the foldenrichment plots in Fig. 1c, d , we observed approximately 15-fold increase for eGFRcrea and 19-fold increase for T2D in the proportion of SNPs reaching the genome-wide significance level of − log 10 (p) − values > 7.3 (p < 5 × 10 −8 ) when comparing the subset with the most stringent conditional association (p = 0.001) to the group with all SNPs (p = 1). In addition, the fold enrichment further reflects the association between eGFRcrea and T2D.
eGFRcrea loci identified with cFDR
We totally detected 137 SNPs significantly (cFDR < 0.05) associated with eGFRcrea conditioned on T2D, which were located on 22 different chromosomes (chr1-13, 15-21), and the results were presented by the conditional Manhattan plot in Fig. 2 . Of these 137 SNPs, 71 SNPs had p values smaller than 1 × 10 −5 (~ 51.8%), while 35 SNPs reached genome-wide significance at 5 × 10 −8 (~ 25.5%) in the original meta-analysis study for eGFRcrea (Pattaro et al. 2016 ). We validated 10 SNPs which were reported to be associated with renal function (details displayed in the Supplementary Table S2 ) (Kottgen et al. 2010; Tin et al. 2013; Pattaro et al. 2016 ). Eight of these 10 SNPs were associated with GFR (Tin et al. 2013; Pattaro et al. 2016) , and two were associated with chronic kidney disease (Kottgen et al. 2010; Pattaro et al. 2016 ). Another 53 SNPs had not been discovered to be eGFRcrea-associated loci, but their annotated genes have been verified to have a relationship with GFR (details displayed in the Supplementary Table S3 ) (Mahajan et al. 2016; Pattaro et al. 2016) . The rest 74 SNPs and their annotated genes were newly found to be associated with eGFRcrea (details displayed in the Supplementary Table S4 ).
T2D loci identified with cFDR
Conditional Manhattan plot for T2D (cFDR < 0.05) showed a total of 19 SNPs significantly associated with T2D given their association with eGFRcrea, which were located on 11 chromosomes (chr1, 3-8, 10-11, 16-17) (Fig. 3) . Of these 19 SNPs, 17 had p values smaller than 1 × 10 −5 , while 6 SNPs reached genome-wide significance at 5 × 10 −8 in the original meta-analysis for T2D (Mahajan et al. 2014) . Of these significant SNPs, three have been validated significantly associated with T2D (details in the Supplementary Table S5) (Li et al. 2013; Mahajan et al. 2014) . Another subset of 13 SNPs had not been reported to be associated with T2D but their annotated genes were mentioned as T2D associated in previous studies (details in the Supplementary Table S6) Voight et al. 2011; Mahajan et al. 2014; Cook and Morris 2016) . SNPs rs2881654 (PPARG, p = 1.7 × 10 −7 , cFDR = 0.0023), rs7079711 (TCF7L2, p = 2.5 × 10 −7 , cFDR = 0.0026) and rs11979110 (KLF14, p = 1 × 10 −7 , cFDR = 0.001) had been detected to be associated with T2D by cFDR, but might be missing under the strict GWAS standard of 5 × 10 −8 (Mahajan et al. 2014) . Above all, we identified three T2D-associated novel loci rs4699049 (SLC9B2), rs3843467 (C5orf67) and rs227375 (MANBA) and detailed information will be displayed in Supplementary Table S7 .
Pleiotropic loci for both eGFRcrea and T2D
To identify the pleiotropic loci between eGFRcrea and T2D, we performed a conjunction cFDR (ccFDR) analysis (ccFDR < 0.05) and constructed a conjunction Manhattan plot for their chromosomal locations. In total, we detected four pleiotropic variants rs4699049 (SLC9B2), rs9381257 (VEGFA and LINC01512), rs227375 (MANBA) and rs1876602 (MTNR1B and SLC36A4) significantly associated with both eGFRcrea and T2D, which were located on three chromosomes (chr. 4, 6, 11) ( Fig. 4 ; Table 1 ). These four SNPs are all found to be associated with both eGFRcrea and T2D. The annotated gene VEGFA by locus rs9381257 has been identified to be associated with eGFRcrea (rs9472135 in VEGFA) (Pattaro et al. 2016) or T2D (rs9472138 in VEGFA) (Mahajan et al. 2014) , but no studies have reported that VEGFA was associated with both eGFRcrea and T2D earlier. 
Functional annotation analysis for pleiotropic loci
A series of bioinformatics analyses in DAVID was conducted to explain the potential functions for the six genes (MANBA, MTNR1B, SLC36A4, SLC9B2, LINC01512 and VEGFA) located in four pleiotropic loci. Five genes (MANBA, MTNR1B, SLC36A4, SLC9B2 and VEGFA) were computed in the results and more detailed information was displayed in the Supplementary Table S8 . As annotated using OMIM databases, MANBA and VEGFA both fell into the entries directly related to kidney or diabetes mellitus. Furthermore, INTERPRO analysis was conducted for the protein annotation, these pleotropic genes were enriched into a variety of proteins, such as glycoside hydrolase family2 (MANBA), melatonin receptor family (MTNR1B), amino acid transporter, transmembrane (SLC36A4), glucose/ribitol dehydrogenase (SLC9B2) and platelet-derived growth factor (VEGFA), which may be closely associated with eGFRcrea or T2D. Gene VEGFA is involved in the pathway of renal cell carcinoma, which is closely related to glucose transport and renal development generated by KEGG. All these results above furnish supporting evidence for our results from the functional aspect. 
Discussion
In this study, we applied the cFDR approach to detect more pleotropic effects and tried to discover more of the missing heritability of two related traits/diseases. Using the pleotropic-informed statistical approach, we can improve the statistic power by 15-20 times to detect the non-null effects and genetic risk factors of both phenotypes compared to the unconditional FDR (Andreassen et al. 2013c) . Moreover, the analysis has clear advantage for correlated traits/diseases, as the method allows for the detection of risk loci regardless of their effect directions when compared to the traditional meta-analysis (Pei et al. 2014) . Furthermore, this method enables identification of shared loci between eGFRcrea and T2D by leveraging the pleiotropic polygenic effects. To the best of our knowledge, we are the first to apply this method to detect common variants associated with both eGFRcrea and T2D. By combining the largely independent datasets of eGFRcrea and T2D, we newly detected a total of 74 loci for eGFRcrea and 3 for T2D with the threshold of cFDR < 0.05, and we also identified four pleiotropic loci (rs227375 located in MANBA, rs1876602 located near MTNR1B and SLC36A4, rs4699049 located in SLC9B2, and rs9381257 located near VEGFA and LINC01512) associated with both eGFRcrea and T2D. The results demonstrated the feasibility of applying the pleiotropic-informed cFDR statistical approach to two related phenotypes: eGFRcrea and T2D. The novel loci detected by pleotropic effects enable us to have a better understanding of these two diseases and may provide some guidance for the subsequent studies of eGFRcrea and/ or T2D.
The SNP rs4699049 mapping to solute carrier family 9 memberB2 (SLC9B2) is a newly identified association with both T2D and eGFRcrea in our study. Sodium/hydrogen exchanger NHA2 is known as NHEDC2 or SLC9B2, which is present in rodent and human β-cells (Deisl et al. 2013) . The expression of NHA2 plays a critical role in insulin secretion capacity of islets (Deisl et al. 2013) . In NHA2-deficient mice, the defection of insulin secretion contributes to impaired glucose tolerance (Deisl et al. 2013) . The SLC9 gene family encodes Na + /H + exchangers (NHEs), which are fatal for transepithelial movement of Na + and HCO 3− in the kidney (Fuster and Alexander 2014) . Another study found that the distribution and expression of NHA2 are especially limited to individual organs, such as in the bone or distal tubules of the kidney (Deisl et al. 2016) . NHA2 resides in the plasma membrane of Madin-Darby canine kidney (MDCK) cells, which are highly enriched and functionally significant in renal tubules (Chintapalli et al. 2015) . To sum up, gene SLC9B2 had been reported to be associated with T2D and kidney functions, but there was no earlier study which illustrated its relationship with both two traits.
Another pleiotropic SNP rs9381257 lay in the intergenic region near gene VEGFA, which encodes vascular endothelial growth factor A. On the one hand, gene VEGFA had been reported to have correlation with kidney in many aspects (Karihaloo et al. 2005; Eremina et al. 2007; Zeggini et al. 2008; Sharma et al. 2011) . Gene VEGFA produced by renal podocytes is a requisite of glomerulogenesis and glomerular filtration barrier formation in animals (Eremina et al. 2007) , and gene VEGFA can affect the number of nephrons by impacting ureteric bud growth during embryogenesis (Karihaloo et al. 2005) . On the other hand, the earlier study demonstrated that this may be a signal for VEGFA associated with T2D (p = 5 × 10 −6 ) in the discovery stage but displayed inconsistent evidence in the replication stage (Zeggini et al. 2008) . Another published study indicated roles in the transcriptional modulation of VEGFA gene in T2D pathogenesis, and the signals near VEGFA probably increases susceptibility of T2D (Sharma et al. 2011) . The functional annotation analysis for gene VEGFA revealed that it is associated with kidney development (GO 0001822) for the biological process and microvascular complications of diabetes 1 (OMIM: #603933). Despite extensive evidence demonstrating the relationship between gene VEGFA with eGFRcrea or T2D, no publication illustrated the association of VEGFA with both eGFRcrea and T2D.
The SNP rs1876602 was identified associated with both traits, which was located in the intergenic region near the genes MTNR1B and SLC36A4. A previous study has shown that the increase expression of MTNR1B is likely to decrease the release of insulin and lead to increasing risk of T2D (Tuomi et al. 2016) . Another research has confirmed amphotericin B with copper (II) ions (AmB-Cu 2+ ) as a complex formed by AmB and is likely to cause upregulation of MTNR1B (Gola et al. 2015) . In this study, it is illustrated that AmB is related to the oxidative injuries of the kidneys but studies about the influence of AmB-Cu 2+ on renal cells are rare (Gola et al. 2015) . Our evidence does not suggest a straightforward relationship between MTNR1B and eGFRcrea and T2D, but may provide a new insight for studying the common mechanism of eGFRcrea and T2D in genetic aspect.
In summary, our study showed pleiotropy effect between eGFRcrea and T2D by leveraging these two GWAS datasets with the cFDR analysis. First, we discovered several novel loci and confirmed some loci that had been identified in previous researches related to eGFRcrea or T2D. In addition, our results provided novel insights into shared genetic influences of eGFRcrea and T2D. Furthermore, we successfully expand the effective sample size for potential pleiotropic loci by detecting non-null effects and hence increasing the probability of these associations being replicated in the independent studies. We adopted cFDR to identify some novel loci that might explain more missing heritability of eGFRcrea or T2D, and effectively found four polygenic effects loci related to both eGFRcrea and T2D. However, our study may also have some limitations. First, it is unclear whether the correlation effect of two phenotypes in the joint consideration would shift the power of cFDR although this question might be partially addressed in future two-sample summarybased Mendelian Randomization (SMR) (Smith and Ebrahim 2004) study. Second, we could not provide information about the same ancestry analysis on the phenotypes (eGFRcrea and T2D) due to a lack of detailed individual-studylevel data and it may have an impact of the results. Third, alternative approaches may be applied to check whether novel loci could still be identified to further confirm novel findings in our study or to furnish an empirical comparison of the relative performance of alternative methods, a topic we wish to pursue in a different area with comprehensive theoretical and simulation approaches. Most of our research results are significant at the statistical level as discovery, for which further clinical replications and further biological experiments are needed to further support our findings.
